Bob Yant

Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation.

Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation.

Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation.

Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation.

Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation.